Loading…
CIK 0002054496 • 4 13F filings • Aug 5, 2025 – Jul 2, 2026
Import this data to Google Sheets with:
=jivedata("eleva-capital-sas-0002054496-filer","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ALPHABET INC | CAP STK CL A | $8.0M | 9.4%Prev: 0.7% | 27,967 SH | Increased+10,826 SH |
| AMAZON COM INC | COM | $3.4M | 3.9% | 16,155 SH | New |
| AMER SPORTS INC | COM SHS | $9.8M | 11.4%Prev: 0.9% | 298,802 SH | Increased+197,108 SH |
| AQUESTIVE THERAPEUTICS INC | COM | $11K | 0.0% | 2,720 SH | New |
| ARCHER AVIATION INC | COM CL A | $111K | 0.1% | 21,534 SH | New |
| ARISTA NETWORKS INC | COM SHS | $5.8M | 6.7% | 46,957 SH | New |
| BOSTON SCIENTIFIC CORP | COM | $1.7M | 1.9% | 26,667 SH | New |
| CG ONCOLOGY INC | COM | $561K | 0.7% | 8,289 SH | New |
| CRH PLC | ORD | $279.1M | 324.5%Prev: 54.0% | 2,654,974 SH | Increased-74,448 SH |
| DISC MEDICINE INC | COM | $327K | 0.4% | 5,115 SH | New |
| EDGEWISE THERAPEUTICS INC | COM | $55K | 0.1% | 17,460 SH | New |
| ESPERION THERAPEUTICS INC | COM | $502K | 0.6% | 183,047 SH | New |
| FENNEC PHARMACEUTICALS INC | COM | $327K | 0.4% | 53,234 SH | New |
| FREEPORT MCMORAN INC | CL B | $133K | 0.2% | 2,258 SH | New |
| MINERALYS THERAPEUTICS INC | COM | $463K | 0.5% | 17,081 SH | New |
| NETFLIX INC | COM | $8.4M | 9.7% | 87,190 SH | New |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $823K | 1.0% | 25,721 SH | New |
| NVIDIA CORPORATION | COM | $9.1M | 10.5% | 52,002 SH | New |
| ON HLDG AG | NAMEN AKT A | $1.7M | 2.0% | 50,150 SH | New |
| ROBINHOOD MKTS INC | COM CL A | $2.2M | 2.5% | 31,625 SH | New |
| SPOTIFY TECHNOLOGY S A | SHS | $1.3M | 1.5% | 2,715 SH | New |
| T-MOBILE US INC | COM | $3.0M | 3.5% | 14,347 SH | New |
| TAIWAN SEMICONDUCTOR MFG LT | SPONSORED ADS | $6.5M | 7.6% | 21,411 SH | New |
| VIRIDIAN THERAPEUTICS INC | COM | $139K | 0.2% | 7,126 SH | New |
| 13F-HR |
| 0002054496-26-000003 |
| $86.0M |
| View |
| Aug 5, 2025 | Q2 2025 | 13F-HR | 0002054496-25-000002 | $463.7M | View |
| Apr 15, 2026 | Q1 2026 | 13F-HR | 0002054496-26-000002 | $343.4M | View |